Clinical Trials Directory

Trials / Terminated

TerminatedNCT02764164

Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS)

Transcranial Direct Current Stimulation for Auditory Hallucinations in Early Onset Schizophrenia

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
8 Years – 25 Years
Healthy volunteers
Not accepted

Summary

Youths diagnosed with early onset schizophrenia will demonstrate amelioration of auditory hallucinations after one week of twice daily treatment with transcranial direct current stimulation (tDCS).

Detailed description

Background: Early onset schizophrenia (EOS) involves positives symptoms such as psychotic behaviors, as well as negative symptoms such as disruptions to normal emotions and behaviors. Antipsychotics are the primary method of treatment in pediatric populations, but can produce unpleasant or dangerous side effects. Medication response is highly variable. Recent evidence demonstrates transcranial Direct Current Stimulation (tDCS) relieving auditory hallucinations (AH) associated with schizophrenia in adults, and to a lesser degree negative and cognitive symptomology. Such studies provide important scientific and technical knowledge that may be applied to pediatric populations. Hypothesis: 1. Primary: Youths with EOS will demonstrate amelioration of AH after administration of tDCS. 2. TDCS will be well-tolerated in pediatric populations with minimal adverse side effects.

Conditions

Interventions

TypeNameDescription
DEVICEIntervention Active tDCSTranscranial direct current stimulation (tDCS) is a form of neurostimulation which uses constant, low current delivered directly to the brain area of interest via small electrodes. Placed over the temporoparietal junction to suppress auditory hallucinations.

Timeline

Start date
2015-01-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2016-05-06
Last updated
2021-03-05
Results posted
2020-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02764164. Inclusion in this directory is not an endorsement.